Back To Search Results

Ossiculoplasty

Editor: Matthew Ng Updated: 1/12/2023 5:53:17 PM

Introduction

Conductive hearing loss results from impaired sound transmission from the external auditory canal across the middle ear structures to the cochlea of the inner ear. A variety of disorders can affect the sound transmission pathway at the level of the ear canal, tympanic membrane, and ossicles before reaching the hearing organ. This topic focuses on surgical correction for restoring ossicular continuity, which is known as ossiculoplasty. Causes of conductive hearing loss secondary to ossicular disorders include trauma, cholesteatoma, chronic infection and inflammation, congenital abnormalities and malformations, neoplasms, and idiopathic.[1]  These can disrupt the ossicular chain and result in conductive hearing loss. Ossiculoplasty was performed as early as the 1950s to restore the middle ear's sound-transmitting mechanism.[2] Ossiculoplasty has continued to evolve, employing various techniques, materials, and prostheses with advantages and limitations.

Anatomy and Physiology

Register For Free And Read The Full Article
Get the answers you need instantly with the StatPearls Clinical Decision Support tool. StatPearls spent the last decade developing the largest and most updated Point-of Care resource ever developed. Earn CME/CE by searching and reading articles.
  • Dropdown arrow Search engine and full access to all medical articles
  • Dropdown arrow 10 free questions in your specialty
  • Dropdown arrow Free CME/CE Activities
  • Dropdown arrow Free daily question in your email
  • Dropdown arrow Save favorite articles to your dashboard
  • Dropdown arrow Emails offering discounts

Learn more about a Subscription to StatPearls Point-of-Care

Anatomy and Physiology

The ossicles (malleus, incus, and stapes) are 3 bones in the middle ear that assist in the mechanical transduction of sound energy. The tympanic membrane collects the sound energy, transmitted across the middle ear along with the 3 middle ear bones and into the fluid-filled cochlea. Collectively, the middle ear bones are known as the ossicular chain. Embryologically, the malleus and incus develop from Meckel’s cartilage of the first pharyngeal arch, the stapes from Reichert’s cartilage of the second pharyngeal arch, and the footplate and annular ligament from the otic capsule.[3][4] The malleus is divided into the head, neck, manubrium, anterior, and lateral processes. The incus is divided into the body, short crus, long crus, and lenticular process. The stapes are divided into the head (capitulum), neck, anterior crus, posterior crus, and footplate.[1] The ossicles are held into position and suspended within the middle ear by various ligaments, muscles, and structural attachments. Laterally, the malleus is attached to the tympanic membrane at the lateral process, manubrium, and umbo. 

Medially, the stapes footplate is secured to the otic capsule by an annular ligament. The intermediate-positioned incus is joined by the other 2 ossicles by the incudomalleolar joint and the incudostapedial joint, which are synovial diarthrodial joints. When sound energy is transmitted across the ossicular chain, it results in vibratory motion of the stapes within the oval window to the cochlea. The classical description of the stapes movement is similar to a piston. However, other vibration patterns and characteristics have been described for the stapes footplate. The differential pressure and impedances at the oval and round windows are required to move cochlear fluid, which forms the basis of neural stimulation for hearing.[5]

The muscles of the middle ear include the tensor tympani and stapedius. In addition to the suspensory and stabilization function, it provides to the ossicular chain that the muscles protect the inner ear from potentially injurious loud sound levels. The tensor tympani attaches to the manubrium of the malleus close to the neck and retracts it medially to stiffen the tympanic membrane. In this manner, it can reduce vibratory transmission across the tympanic membrane. The stapedius attaches to the posterior aspect of the stapes head adjacent to the neck and dampens vibrations into the oval window when loud sounds trigger the acoustic reflex.[3] Suppose the muscles mentioned above are detached from their respective ossicles or lose function from disease or surgery. In that case, there is no way to restore the protective effects conferred by the muscles during ossiculoplasty.

Suppose sound energy that travels in an air medium enters the external auditory canal directly to the stapes footplate without a tympanic membrane, middle ear, and ossicles. In that case, an impedance mismatch occurs with only 0.1% of acoustic energy reaching the inner ear.[2]  To overcome this mismatch, the ossicular chain contributes to an impedance-matching system and transmits over 90% of acoustic energy into the inner ear. The mechanism of how the middle ear overcomes the impedance change is primarily acquired through the area effect of the tympanic membrane and the lever ratio of the ossicular chain. The area effect is the difference between the surface area of the tympanic membrane relative to the surface area of the stapes footplate where sound must travel. Sound is concentrated by a factor of 17 to 20-fold based on the ratio of surface areas of the recipient tympanic membrane to the target stapes footplate (between 17 and 20 to 1).[2] The ossicular lever effect is the ratio of the malleus manubrium length to the incus long process length, providing a mechanical advantage. A ratio of 1.3 to 1 has been reported based on the relative lengths.[1] When considering both area and lever effects, the overall middle ear mechanical advantage conferred is 22 to 1 (the product of the area and lever ratios). Overall, the impedance matching function of the ossicular chain produces approximately 20 to 30 dB gain in sound pressure.[2] When ossiculoplasty is performed, continuity of the ossicular chain may be surgically restored, but the lever effect cannot be replicated.

Indications

Ossiculoplasty aims to reestablish ossicular chain continuity and improve the air conduction thresholds in patients with conductive hearing loss. Chronic otitis media and its sequelae, such as cholesteatoma and ossicular erosion, account for over 80% of ossicular chain disruption cases.[6] The remaining cases are due to blunt and penetrating trauma causing disarticulation, congenital ossicular fixation, acquired ossicular fixation from tympanosclerosis, congenital malformations, congenital absence of ossicles, otosclerosis, and middle ear neoplasms.[1][7] The incus is involved in most of these cases, particularly the long process, followed by the stapes.[8][9] Approximately half of the cases involve more than 1 ossicles.[10][11] In up to 55% of conductive hearing loss cases, ossicular discontinuity or fixation was found to be responsible.[12] Restoring ossicular chain continuity is vital, as prolonged conductive hearing loss can lead to poor language development, cognition, and learning.[13][14]

Contraindications

Ongoing middle ear infection (otitis media) is a contraindication to ossicular chain reconstruction. However, relative contraindications include factors that would result in suboptimal hearing improvement, such as a reduced middle ear space, repeated surgical failures using similar prostheses, stapes fixation/malformation, and only a hearing ear.[7]  Hearing assistive devices, such as conventional hearing aids and bone-conduction devices, must be offered to the patient as an alternative to hearing habilitation. A stable, well-aerated middle ear environment is critical for optimal sound conduction. A contracted middle ear space can restrict the movement of the tympanic membrane, ossicular chain, and round window, resulting in 35 to 55 dB conductive hearing loss.[15] Middle ear pathology resulting from poor ventilation is significantly more detrimental to ossiculoplasty success than surgical technique and prosthetic factors.[16][17] Negative middle ear pressure, poor mastoid pneumatization, effusion, persistent Eustachian tube dysfunction, granulation tissue, middle ear fibrosis, adhesive disease, and tympanic membrane perforations can all affect the efficiency of sound transmission. It must be addressed prior or in conjunction with ossiculoplasty.[2][18] Reduced stapes footplate mobility, absence of stapes superstructure, or an improperly aligned stapes superstructure can result in suboptimal ossicular coupling, increased risk of prosthesis displacement, and surgical failure.[19][20]

Equipment

The following equipment may be needed:

  • Operating microscope
  • Ossicle holder
  • Microdrill for sculpting
  • Otologic instrumentation tray
  • Ossicular prosthesis

There are 3 synthetic ossicular prostheses: partial ossicular replacement prosthesis (PORP), total ossicular replacement prosthesis (TORP), and incus interpositional or incus replacement prosthesis. PORP links an intact stapes suprastructure to the malleus or tympanic membrane. TORP links the stapes footplate to the malleus or tympanic membrane. An incus interpositional prosthesis is used when the long process is compromised. It connects the stapes superstructure to the remnant incus long process. An incus replacement prosthesis is used when the incus is missing, and the prosthesis is placed between the manubrium and stapes capitulum. Ossiculoplasty improves hearing with a success rate of 75% for PORP and 68% for TORP at 12 to 18 months.[20] The success at 5 years for PORP and TORP is 66% and 33%, respectively.[16] The use of autologous versus artificial synthetic materials for prostheses has been debated since the 1950s. Autografts were first used in ossicular reconstruction in 1957 by Hall.[21] The advantage of using autografts from ossicles, cortical bone, and cartilage is the low risk of extrusion.[7] The sculpted incus body is the most commonly used autograft. It offers convenient availability in the same surgical field. The disadvantages of autografts include insufficient ossicular body mass if significant erosion has occurred secondary to disease, prolonged intraoperative time for sculpting, future resorption by osteitis, fixation, and risk of residual cholesteatoma.[7][8]

The first use of artificial ossicular prostheses dates back to 1952 with vinyl-acryl plastic. Over the last few decades, prostheses have been manufactured from plastics (polyethylene, polytetrafluorethylene, Teflon, plastipore, proplast, silicone), metals (stainless steel, titanium, platinum, gold, tantalum), and biomaterials (aluminum oxide ceramic, bioglass, Ceravital, hydroxyapatite, carbon).[2][7][22] Prostheses must be inert in the middle cavity to prevent foreign body reactions and chronic inflammation, as they can result in an osteolytic process that leads to ossicular remnant necrosis.[23] Disadvantages of allograft materials such as polyethylene, plastipore, Teflon, and Ceravital include inflammatory middle ear reactions, biodegradation, prosthesis extrusion, displacement, and migration into the inner ear.[8][22][24][25] 

Hydroxyapatite is composed of calcium phosphate ceramic, similar to bone mineral, and has good biocompatibility.[26] Grote first used it in the 1980s.[27] Extrusion rates are 4% to 16%, with lower extrusion (<2%) when a cartilage graft is interposed between the implant and the tympanic membrane.[28][29] However, hydroxyapatite is brittle, challenging to sculpt, and difficult to place due to its bulk.[30][31][32][30] Titanium is lightweight, rigid, and biocompatible, and has recently gained popularity.[2][33] It is easier to conform to different shapes and can be more precisely sized compared to hydroxyapatite, facilitating its placement. The extrusion rate is 1% to 2%, and hearing results are similar to hydroxyapatite or autografts.[34][35][36] Bone cement serves as a good adjunct for ossiculoplasty. It is easy to prepare and apply with fast setting times and good biocompatibility. It can be molded to augment the ossicular remnant, allowing ossicle preservation. Ninety percent of patients who underwent bone cement reconstruction have reported an air-bone gap closure of 20dB or better.[37][38] Today, autograft and homograft prostheses have largely been replaced by the more readily available, versatile, and durable artificial synthetic prostheses.[2] A survey by Goldenberg et al showed that 70% of otologists prefer synthetic material to bone (25.15%) or cartilage (4.4%).[17] There is no statistically significant difference in hearing improvement between autograft and synthetic prostheses.[18][39]  Surgeons ultimately opt for the material proven to give the best results in their hands.[40][34]

Personnel

The following personnel may be needed to carry out this technique:

  • Otolaryngologist
  • Anesthesiologist
  • Surgical technician
  • Circulating nurse

Preparation

The patient with conductive hearing loss should undergo a complete history and physical with a focused head and neck exam, including an otomicroscopic exam and tuning fork evaluation. The sound conduction pathways must be visually inspected to determine the cause and contributory factors of conductive hearing loss. This includes ear canal patency, tympanic membrane integrity and position, middle ear aeration, and retrotympanic abnormalities. Tuning fork tests include Weber and Rinne tests.

In the setting of conductive hearing loss, the Weber test lateralizes to the side of the conductive hearing loss, and the Rinne test suggests improved audibility better via bone conduction than air conduction. 512 Hz and 1024 Hz forks are recommended to help estimate the degree of conductive hearing loss. Preoperative pure tone audiogram assesses the nature and degree of hearing loss and confirms the findings on the tuning fork exams. Impedance audiometry offers information regarding tympanic membrane compliance and acoustic reflex integrity. CT scan of the temporal bones is obtained to provide information on ossicular integrity, continuity, and co-existing tympanomastoid disease that affects surgical planning.[8] Before surgery, informed consent is obtained. Risks include bleeding, infection, ossicular prosthesis displacement (immediate or delayed) or extrusion, hearing loss, dizziness, altered taste, facial nerve injury leading to facial paralysis, stapes subluxation leading to deafness, perilymphatic fistula, and need for additional future surgery. The alternative options for surgery to improve hearing include conventional hearing aids or bone conduction devices.

Technique or Treatment

Ossiculoplasty may be performed in IV sedation/local anesthesia or general anesthesia, depending on whether other otologic procedures are planned. If surgical eradication of the middle ear or mastoid disease (tympanomastoidectomy) is planned, general anesthesia is administered in conjunction with intraoperative facial nerve monitoring. If the plan is to restore ossicular continuity in an ear without active disease, for example, in a planned staged ear surgery, the tympanomeatal flap may be raised and ossiculoplasty performed under IV sedation/local anesthesia.

The ear is prepped and draped in a sterile fashion. Access to the middle ear cavity can be obtained through the transcanal or postauricular approach. In either approach, a tympanomeatal flap is raised to expose the middle ear and access the ossicular chain. The postauricular approach is better suited for patients who have a narrow external auditory canal or prominent bony prominences where a transcanal approach would be made difficult or if a concurrent mastoidectomy is planned. In both approaches, a local anesthetic containing a vasoconstricting agent (ie, 1% lidocaine with 1: 100,000 epinephrine) is injected into the ear canal to promote local anesthesia and hemostasis. This is done under direct visualization of the operating microscope to precisely deliver the injection into the ear canal at the bony-cartilaginous junction in the subperiosteal plane to result in a diffuse blanch.

Transcanal Approach

The tympanomeatal flap is elevated via a transcanal approach by making 2 8 mm radial longitudinal incisions lateral to the annulus superiorly at the tympanosquamous suture line (12 o’clock) and inferiorly (6 o’clock). A transverse incision joins the 2 incisions laterally to form a medially-based U-shaped flap. The canal skin and periosteum are then elevated in continuity with the fibrous annulus, which is raised out of its bony groove. The tympanomeatal flap is then reflected forward to access the posterior mesotympanum and ossicles. 

Postauricular Approach

Ossiculoplasty in chronic ear surgery usually occurs as the last step after tympanomastoidectomy and removal of obstructive or cholesteatomatous disease. In this case, the middle ear is already widely exposed, and ossiculoplasty and eardrum grafting (tympanoplasty) are performed. If tympanomastoidectomy is not performed and a posterior auricular approach is chosen, ear canal incisions, similar to that described for the transcanal approach, are created to allow a tympanomeatal flap to be raised. A posterior auricular incision is created and carried down to the plane lateral to the temporalis fascia. An incision through the musculoperiosteum is created along the temporal line, and another perpendicular musculoperiosteal incision is made posterior to the cartilaginous ear canal and toward the mastoid tip. The anterior-based musculoperiosteal flap created from these incisions is elevated toward the membranous ear canal, and entry is made into the bony ear canal. The posterior canal skin of the bony canal is elevated medially until the tympanomeatal flap incisions are reached. A Perkins retractor retracts the auricle and posterior canal skin forward. The tympanomeatal flap can now be raised, and the middle ear can be entered. If ear canal patency is compromised by an anterior canal wall bulge or hypertrophic tympanic ring, the canal skin overlying the bony prominence is elevated and reduced with an otologic drill until adequate access to the middle ear is obtained. 

Prosthesis Placement

Once the middle ear cavity is accessed and exposed, the ossicles are inspected for defects and gently palpated to assess mobility and continuity. Identify the most appropriate ossicular reconstruction solution (autologous vs. synthetic/artificial). Stapes footplate mobility is essential for hearing success. If the stapes capitulum is intact, a PORP can be used. A TORP can be used if the stapes footplate is intact and mobile. The platform of the TORP or PORP can be positioned under the manubrium or undersurface of the native or grafted tympanic membrane. Autologous cartilage is harvested from either the tragus or conchal bowl to be used as a shield or cap over the prosthesis platform to prevent prosthesis extrusion. If the manubrium is intact but medialized or foreshortened, the tensor tympani tendon should be transected, and the manubrium lateralized to accommodate the ossicular reconstruction better.

The prosthesis is then trimmed to a length that would span the distance from the mobile stapes superstructure or footplate medially to the tympanic membrane or manubrium laterally. The prosthesis length must be trimmed to the length that accounts for the cartilage shield's thickness or cap on the prosthesis platform. The final placement of the prosthesis should result in good stability and not prone to dislocation or displacement. A gelatin sponge soaked in to topical antibiotic drops can be used to pack around the reconstruction to provide additional prosthesis stability. Some metallic prostheses feature a crimpable cage that can be affixed to the capitulum for further stabilization. The tympanomeatal flap or grafted tympanic membrane is placed over the cartilage-prosthetic complex. An antibiotic-soaked gelatin sponge is placed lateral to the tympanic membrane or graft to secure its position. Postoperatively, patients are seen 1 week after surgery. Antibiotic drops are started at the first postoperative visit for a 3-week course. After that, the canal is carefully debrided free of all packing material. Audiometry is performed 3 months after surgery to assess hearing results.

Complications

The predominant complications of ossiculoplasty include failure to improve the conductive hearing loss, necrosis of an autologous osseous graft or remnant native ossicles, and prosthesis extrusion/migration. More rare complications include fracture of the stapes superstructure, displacement of stapes, disruption of the annular ligament of the oval window leading to perilymphatic fistula, severe or complete sensorineural hearing loss, and vertigo.[7] Factors that influence surgical failure include middle ear pathology, type of prosthesis, ossicular chain condition at the time of ossiculoplasty, surgical technique, external auditory canal wall status in cases of canal wall down mastoid surgery, and staging of ossiculoplasty. The most common reason for surgical failure is persistent middle ear disease followed by prosthesis displacement or migration, which results in maximum conductive hearing loss.[2] Middle ear pathology (middle ear drainage, chronic otitis media, cholesteatoma) accounts for up to 56% of all surgical failures, mostly due to atelectasis.[2][16][28][41][42] Loss of hearing can occur immediately after surgery or be delayed. Poor hearing in the postoperative period may be due to middle ear effusion or ongoing middle ear disease, graft failure, or displaced prosthesis.[43] Delayed hearing loss after an initial period of improvement is most likely due to cholesteatoma recurrence or recidivistic disease, delayed graft failure, prosthesis displacement, or the formation of scarring around the prosthesis.[44] 

Traditionally, closure of the air-bone gap on pure tone audiometry below 20 dB has been the marker of surgical success.[43] The Ossiculoplasty Outcome Parameter Staging (OOPS) index was developed to predict hearing outcomes in patients after ossiculoplasty based on preoperative patient characteristics as well as intraoperative findings such as the presence of middle ear drainage,  normal vs. fibrotic middle ear mucosa, presence of malleus, type of surgery (canal wall up vs. canal wall down mastoidectomy), and if it is revision surgery.[45] The OOPS index has been useful in helping providers predict surgical success, pinpoint patients at risk for surgical complications, compare different surgical techniques and prostheses, and assess progression in surgical ability.[43] The OOPS is significant in predicting both short-term and long-term hearing success.[43][45] 

Factors that increase the risk of complications after ossiculoplasty include poor hearing results on the first postoperative audiometry, absence of malleus, middle ear disease, ETD, recurrent otitis media, tobacco smoking, and inability to perform Valsalva.[44][46][47][48][49][50]  To improve ossiculoplasty success rates, a delayed ossicular chain reconstruction has been recommended for patients with a significant disease requiring extensive middle ear and mastoid surgery, canal wall down mastoidectomy, residual cholesteatoma, and excessive middle ear mucosa resection.[2][51] Postoperatively, patients are followed annually by audiometry to assess the long-term stability of hearing and an office otomicroscopic examination to assess whether there is a return of middle ear disease. For patients with poor postoperative audiometric outcomes, the reasons for failure need to be determined, and decisions need to be made to see any factors that may be corrected. In some cases, CT imaging may be required to assess the prosthesis position and whether persistent tympanomastoid disease might contribute to the poor result. Revision surgery may be necessary.

Clinical Significance

Since the 1950s, ossiculoplasty has been performed in patients with conductive hearing loss associated with ossicular chain disruption, leading to significant improvements in speech, social development, and overall quality of life. However, the rates of air-bone gap closure on audiometry, long-term continuation of postoperative hearing improvement, and overall surgical success have varied. Many prosthetics and surgical techniques have been described over the last half-century, with no overall consensus on the ideal treatment method. This further highlights the need for additional research to determine the optimal algorithm of hearing habilitation. Healthcare providers that deal with conductive hearing loss and ossicular chain disruption must be well-informed on the etiology of middle ear disease, the anatomy of ear structures, diagnostic practices, chronic ear management, surgical repair techniques, postoperative care, and mitigation of complications.

Enhancing Healthcare Team Outcomes

Managing conductive hearing loss due to ossicular chain disruption requires a multidisciplinary team of otolaryngologists, audiologists, anesthesiologists, and speech therapists. Early diagnosis and treatment of conductive hearing loss are essential for long-term speech fluency and social function. Patients with chronic ear disease, trauma, and resulting hearing loss should be referred by their primary care physicians to audiologists for hearing evaluation. If ossicular chain disruption is suspected from audiometry and imaging, a referral should be sent to an otolaryngologist. Postoperatively, patients should be followed by an otolaryngologist and an audiologist to monitor surgical outcomes and undergo postoperative audiometry to assess hearing improvement and long-term stability of hearing results. Speech therapy should continue even after surgical repair for children to enhance speech outcomes.

References


[1]

Kamrava B, Roehm PC. Systematic Review of Ossicular Chain Anatomy: Strategic Planning for Development of Novel Middle Ear Prostheses. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery. 2017 Aug:157(2):190-200. doi: 10.1177/0194599817701717. Epub 2017 May 2     [PubMed PMID: 28463590]

Level 1 (high-level) evidence

[2]

Javia LR, Ruckenstein MJ. Ossiculoplasty. Otolaryngologic clinics of North America. 2006 Dec:39(6):1177-89     [PubMed PMID: 17097440]


[3]

Helwany M, Arbor TC, Tadi P. Embryology, Ear. StatPearls. 2024 Jan:():     [PubMed PMID: 32491520]


[4]

HANSON JR, ANSON BJ, BAST TH. The early embryology of the auditory ossicles in man. Quarterly bulletin. Northwestern University (Evanston, Ill.). Medical School. 1959:33(4):358-79     [PubMed PMID: 14399619]


[5]

Pickles JO. Auditory pathways: anatomy and physiology. Handbook of clinical neurology. 2015:129():3-25. doi: 10.1016/B978-0-444-62630-1.00001-9. Epub     [PubMed PMID: 25726260]

Level 3 (low-level) evidence

[6]

Haggard M. Screening children's hearing. British journal of audiology. 1992 Aug:26(4):209-15     [PubMed PMID: 1446184]


[7]

Mudhol RS, Naragund AI, Shruthi VS. Ossiculoplasty: revisited. Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India. 2013 Dec:65(Suppl 3):451-4. doi: 10.1007/s12070-011-0472-7. Epub 2012 Jan 13     [PubMed PMID: 24427696]


[8]

Lamba GK, Sohal BS, Goyal JP. Ossiculoplasty: A Prospective Study on 50 Patients Using Various Graft Materials. Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India. 2019 Nov:71(Suppl 2):1140-1146. doi: 10.1007/s12070-018-01571-0. Epub 2019 Jan 3     [PubMed PMID: 31750139]


[9]

Tos M. Pathology of the ossicular chain in various chronic middle ear diseases. The Journal of laryngology and otology. 1979 Aug:93(8):769-80     [PubMed PMID: 490029]


[10]

Albera R, Canale A, Piumetto E, Lacilla M, Dagna F. Ossicular chain lesions in cholesteatoma. Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale. 2012 Oct:32(5):309-13     [PubMed PMID: 23326010]


[11]

Jeng FC, Tsai MH, Brown CJ. Relationship of preoperative findings and ossicular discontinuity in chronic otitis media. Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology. 2003 Jan:24(1):29-32     [PubMed PMID: 12544024]


[12]

Austin DF. Sound conduction of the diseased ear. The Journal of laryngology and otology. 1978 May:92(5):367-93     [PubMed PMID: 349104]

Level 3 (low-level) evidence

[13]

Lieu JE. Unilateral hearing loss in children: speech-language and school performance. B-ENT. 2013:Suppl 21():107-15     [PubMed PMID: 24383229]

Level 2 (mid-level) evidence

[14]

Fischer C, Lieu J. Unilateral hearing loss is associated with a negative effect on language scores in adolescents. International journal of pediatric otorhinolaryngology. 2014 Oct:78(10):1611-7. doi: 10.1016/j.ijporl.2014.07.005. Epub 2014 Jul 12     [PubMed PMID: 25081604]

Level 2 (mid-level) evidence

[15]

Merchant SN, McKenna MJ, Mehta RP, Ravicz ME, Rosowski JJ. Middle ear mechanics of Type III tympanoplasty (stapes columella): II. Clinical studies. Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology. 2003 Mar:24(2):186-94     [PubMed PMID: 12621330]

Level 2 (mid-level) evidence

[16]

Yung M. Long-term results of ossiculoplasty: reasons for surgical failure. Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology. 2006 Jan:27(1):20-6     [PubMed PMID: 16371842]

Level 2 (mid-level) evidence

[17]

Goldenberg RA, Emmet JR. Current use of implants in middle ear surgery. Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology. 2001 Mar:22(2):145-52     [PubMed PMID: 11300260]


[18]

Chavan SS, Jain PV, Vedi JN, Rai DK, Kadri H. Ossiculoplasty: a prospective study of 80 cases. Iranian journal of otorhinolaryngology. 2014 Jul:26(76):143-50     [PubMed PMID: 25009804]

Level 3 (low-level) evidence

[19]

Cox MD, Russell JS, Dornhoffer JL. TORP ossiculoplasty outcomes with and without a stapes footplate prosthesis. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery. 2015 Mar:152(3):501-5. doi: 10.1177/0194599814564538. Epub 2014 Dec 30     [PubMed PMID: 25550225]

Level 2 (mid-level) evidence

[20]

Dumont J, Abouzayd M, Le Louarn A, Pondaven S, Bakhos D, Lescanne E. Total and partial ossiculoplasty in children: Audiological results and predictive factors. European annals of otorhinolaryngology, head and neck diseases. 2019 Jun:136(3):161-164. doi: 10.1016/j.anorl.2019.02.012. Epub 2019 Mar 14     [PubMed PMID: 30880034]


[21]

HALL A, RYTZNER C. Stapedectomy and autotransplantation of ossicles. Acta oto-laryngologica. 1957 Apr:47(4):318-24     [PubMed PMID: 13424240]


[22]

Yung MW. Literature review of alloplastic materials in ossiculoplasty. The Journal of laryngology and otology. 2003 Jun:117(6):431-6     [PubMed PMID: 12825564]


[23]

McGee M, Hough JV. Ossiculoplasty. Otolaryngologic clinics of North America. 1999 Jun:32(3):471-88     [PubMed PMID: 10393780]


[24]

GOLDMAN JL, NALEBUFF DJ, DRUSS JG. Experimental observations on prosthetic materials in stapedial surgery with special reference to the use of teflon. The Laryngoscope. 1962 Feb:72():169-81     [PubMed PMID: 13899815]


[25]

Brewis C, Orrell J, Yung MW. Ceravital revisited: lessons to be learned. Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology. 2003 Jan:24(1):20-3     [PubMed PMID: 12544022]


[26]

van Blitterswijk CA, Grote JJ. Biocompatibility of clinically applied hydroxylapatite ceramic. The Annals of otology, rhinology & laryngology. Supplement. 1990 Feb:144():3-11     [PubMed PMID: 2154157]


[27]

Grote JJ. Reconstruction of the ossicular chain with hydroxyapatite prostheses. The American journal of otology. 1987 Sep:8(5):396-401     [PubMed PMID: 2825526]


[28]

House JW, Teufert KB. Extrusion rates and hearing results in ossicular reconstruction. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery. 2001 Sep:125(3):135-41     [PubMed PMID: 11555743]

Level 2 (mid-level) evidence

[29]

Kobayashi T, Gyo K, Shinohara T, Yanagihara N. Ossicular reconstruction using hydroxyapatite prostheses with interposed cartilage. American journal of otolaryngology. 2002 Jul-Aug:23(4):222-7     [PubMed PMID: 12105787]


[30]

Meijer AG, Segenhout HM, Albers FW, van de Want HJ. Histopathology of biocompatible hydroxylapatite-polyethylene composite in ossiculoplasty. ORL; journal for oto-rhino-laryngology and its related specialties. 2002 May-Jun:64(3):173-9     [PubMed PMID: 12037383]


[31]

Grote JJ. Reconstruction of the middle ear with hydroxylapatite implants: long-term results. The Annals of otology, rhinology & laryngology. Supplement. 1990 Feb:144():12-6     [PubMed PMID: 2154156]


[32]

Shinohara T, Gyo K, Saiki T, Yanagihara N. Ossiculoplasty using hydroxyapatite prostheses: long-term results. Clinical otolaryngology and allied sciences. 2000 Aug:25(4):287-92     [PubMed PMID: 10971535]


[33]

Alaani A, Raut VV. Kurz titanium prosthesis ossiculoplasty--follow-up statistical analysis of factors affecting one year hearing results. Auris, nasus, larynx. 2010 Apr:37(2):150-4. doi: 10.1016/j.anl.2009.05.004. Epub 2009 Jun 23     [PubMed PMID: 19553041]


[34]

Gardner EK, Jackson CG, Kaylie DM. Results with titanium ossicular reconstruction prostheses. The Laryngoscope. 2004 Jan:114(1):65-70     [PubMed PMID: 14709997]

Level 2 (mid-level) evidence

[35]

Ho SY, Battista RA, Wiet RJ. Early results with titanium ossicular implants. Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology. 2003 Mar:24(2):149-52     [PubMed PMID: 12621325]

Level 2 (mid-level) evidence

[36]

Zeitler DM, Lalwani AK. Are postoperative hearing results better with titanium ossicular reconstruction prostheses? The Laryngoscope. 2010 Jan:120(1):2-3. doi: 10.1002/lary.20738. Epub     [PubMed PMID: 20024900]


[37]

Babu S, Seidman MD. Ossicular reconstruction using bone cement. Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology. 2004 Mar:25(2):98-101     [PubMed PMID: 15021766]

Level 2 (mid-level) evidence

[38]

Ozer E, Bayazit YA, Kanlikama M, Mumbuc S, Ozen Z. Incudostapedial rebridging ossiculoplasty with bone cement. Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology. 2002 Sep:23(5):643-6     [PubMed PMID: 12218612]

Level 2 (mid-level) evidence

[39]

Malard O, Daculsi G, Toquet J, Beauvillain De Montreuil C, Legent F, Bordure P. [Autografts versus biomaterials for ossiculoplasty with normal stapes; a comparative analysis of functional outcome in 100 cases]. Annales d'oto-laryngologie et de chirurgie cervico faciale : bulletin de la Societe d'oto-laryngologie des hopitaux de Paris. 2001 Sep:118(4):225-31     [PubMed PMID: 11679841]

Level 2 (mid-level) evidence

[40]

Dalchow CV, Grün D, Stupp HF. Reconstruction of the ossicular chain with titanium implants. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery. 2001 Dec:125(6):628-30     [PubMed PMID: 11743465]


[41]

Vartiainen E, Nuutinen J. Long-term hearing results of one-stage tympanoplasty for chronic otitis media. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery. 1992:249(6):329-31     [PubMed PMID: 1418943]


[42]

Rondini-Gilli E, Grayeli AB, Borges Crosara PF, El Garem H, Mosnier I, Bouccara D, Sterkers O. Ossiculoplasty with total hydroxylapatite prostheses anatomical and functional outcomes. Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology. 2003 Jul:24(4):543-7     [PubMed PMID: 12851543]

Level 2 (mid-level) evidence

[43]

Cox MD, Trinidade A, Russell JS, Dornhoffer JL. Long-Term Hearing Results After Ossiculoplasty. Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology. 2017 Apr:38(4):510-515. doi: 10.1097/MAO.0000000000001339. Epub     [PubMed PMID: 28106625]


[44]

Cox MD, Page JC, Trinidade A, Dornhoffer JL. Long-term Complications and Surgical Failures After Ossiculoplasty. Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology. 2017 Dec:38(10):1450-1455. doi: 10.1097/MAO.0000000000001572. Epub     [PubMed PMID: 28984803]


[45]

Dornhoffer JL, Gardner E. Prognostic factors in ossiculoplasty: a statistical staging system. Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology. 2001 May:22(3):299-304     [PubMed PMID: 11347630]

Level 2 (mid-level) evidence

[46]

Dornhoffer JR, Cox MD, Dornhoffer JL. The Association of Valsalva Status With Smoking and Its Impact on Ossiculoplasty Outcomes and Complications. Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology. 2016 Aug:37(7):914-8. doi: 10.1097/MAO.0000000000001098. Epub     [PubMed PMID: 27273400]


[47]

De Vos C, Gersdorff M, Gérard JM. Prognostic factors in ossiculoplasty. Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology. 2007 Jan:28(1):61-7     [PubMed PMID: 17195748]

Level 2 (mid-level) evidence

[48]

Black B. Ossiculoplasty prognosis: the spite method of assessment. The American journal of otology. 1992 Nov:13(6):544-51     [PubMed PMID: 1449182]


[49]

Truy E, Naiman AN, Pavillon C, Abedipour D, Lina-Granade G, Rabilloud M. Hydroxyapatite versus titanium ossiculoplasty. Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology. 2007 Jun:28(4):492-8     [PubMed PMID: 17529851]

Level 2 (mid-level) evidence

[50]

Vrabec JT, Stierman K, Grady JJ. Hydroxyapatite prosthesis extrusion. Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology. 2002 Sep:23(5):653-6     [PubMed PMID: 12218614]

Level 3 (low-level) evidence

[51]

Kim HH, Battista RA, Kumar A, Wiet RJ. Should ossicular reconstruction be staged following tympanomastoidectomy. The Laryngoscope. 2006 Jan:116(1):47-51     [PubMed PMID: 16481808]

Level 2 (mid-level) evidence